Diatheva has developed a range of assays based on ELISA technology for the semiquantitative detection of specific IgG and IgM immunoglobulins for SARS-CoV-2
The kits use the virus nucleocapsid protein as a diagnostic marker.
Principle of the assay
COVID-19 ELISA IgG DIATHEVA kit and COVID-19 ELISA IgM DIATHEVA kit are Immunoenzymatic essay (ELISA) for the determination of IgG and IgM antibodies to the COVID-19 coronavirus Nucleocapsid (N) antigen from plasma and serum.
Reliability: the kits provide positive and negative controls
Turn around time is less than 2 hours and 30 minutes
Convenience: all reagents are ready to use providing continuity, stability and a long shelf life